OBJECTIVE: To determine the role of abdominal CT in assessment of severity and prognosis of patients with acute gastrointestinal (GI) graft-vs-host disease (GVHD). METHODS: During 2000-2004, 41 patients with a clinical diagnosis of acute GI-GVHD were evaluated. CTs were examined for intestinal and extra-intestinal abnormalities, and correlated with clinical staging and outcome. RESULTS: 20 patients had GVHD clinical Stage I-II and 21 had Stage III-IV. 39 (95%) had abnormal CT appearances. The most consistent finding was bowel wall thickening: small (n=14, 34%) or large (n=5, 12%) bowel, or both (n=20, 49%). Other manifestations included bowel dilatation (n=7, 17%), mucosal enhancement (n=6, 15%) and gastric wall thickening (n=9, 38%). Extra-intestinal findings included mesenteric stranding (n=25, 61%), ascites (n=17, 41%), biliary abnormalities (n=12, 29%) and urinary excretion of orally administered gastrografin (n=12, 44%). Diffuse small-bowel thickening and any involvement of the large bowel were associated with severe clinical presentation. Diffuse small-bowel disease correlated with poor prognosis. 8 of 21 patients responded to therapy, compared with 15 of 20 patients with other patterns (p=0.02), and the cumulative incidence of GVHD-related death was 62% and 24%, respectively (p=0.01). Overall survival was not significantly different between patients with diffuse small-bowel disease and patients with other patterns (p=0.31). Colonic disease correlated with severity of GVHD (p=0.04), but not with response to therapy or prognosis (p=0.45). CONCLUSION: GVHD often presented with abdominal CT abnormalities. Diffuse small-bowel disease was associated with poor therapeutic response. CT may play a role in supporting clinical diagnosis of GI GVHD and determining prognosis.
OBJECTIVE: To determine the role of abdominal CT in assessment of severity and prognosis of patients with acute gastrointestinal (GI) graft-vs-host disease (GVHD). METHODS: During 2000-2004, 41 patients with a clinical diagnosis of acute GI-GVHD were evaluated. CTs were examined for intestinal and extra-intestinal abnormalities, and correlated with clinical staging and outcome. RESULTS: 20 patients had GVHD clinical Stage I-II and 21 had Stage III-IV. 39 (95%) had abnormal CT appearances. The most consistent finding was bowel wall thickening: small (n=14, 34%) or large (n=5, 12%) bowel, or both (n=20, 49%). Other manifestations included bowel dilatation (n=7, 17%), mucosal enhancement (n=6, 15%) and gastric wall thickening (n=9, 38%). Extra-intestinal findings included mesenteric stranding (n=25, 61%), ascites (n=17, 41%), biliary abnormalities (n=12, 29%) and urinary excretion of orally administered gastrografin (n=12, 44%). Diffuse small-bowel thickening and any involvement of the large bowel were associated with severe clinical presentation. Diffuse small-bowel disease correlated with poor prognosis. 8 of 21 patients responded to therapy, compared with 15 of 20 patients with other patterns (p=0.02), and the cumulative incidence of GVHD-related death was 62% and 24%, respectively (p=0.01). Overall survival was not significantly different between patients with diffuse small-bowel disease and patients with other patterns (p=0.31). Colonic disease correlated with severity of GVHD (p=0.04), but not with response to therapy or prognosis (p=0.45). CONCLUSION:GVHD often presented with abdominal CT abnormalities. Diffuse small-bowel disease was associated with poor therapeutic response. CT may play a role in supporting clinical diagnosis of GI GVHD and determining prognosis.
Authors: H Glucksberg; R Storb; A Fefer; C D Buckner; P E Neiman; R A Clift; K G Lerner; E D Thomas Journal: Transplantation Date: 1974-10 Impact factor: 4.939
Authors: Hans-Joachim Mentzel; Karim Kentouche; Hartwig Kosmehl; Bemd Gruhn; Susanna Vogt; Axel Sauerbrey; Werner Behrendt; Dietlinde Fuchs; Felix Zintl; Werner A Kaiser Journal: Pediatr Radiol Date: 2002-03
Authors: M Cruz-Correa; A Poonawala; S C Abraham; T T Wu; M Zahurak; G Vogelsang; A N Kalloo; L A Lee Journal: Endoscopy Date: 2002-10 Impact factor: 10.093
Authors: A Schulenburg; K Turetschek; F Wrba; H Vogelsang; H T Greinix; F Keil; M Mitterbauer; P Kalhs Journal: Ann Hematol Date: 2003-11-13 Impact factor: 3.673
Authors: Babak N Kalantari; Koenraad J Mortelé; Vito Cantisani; Silvia Ondategui; Jonathan N Glickman; Adheet Gogate; Pablo R Ros; Stuart G Silverman Journal: AJR Am J Roentgenol Date: 2003-12 Impact factor: 3.959
Authors: Johannes Budjan; Henrik J Michaely; Ulrike Attenberger; Stefan Haneder; Daniela Heidenreich; Sebastian Kreil; Florian Nolte; Wolf-Karsten Hofmann; Stefan O Schoenberg; Stefan A Klein Journal: Eur Radiol Date: 2014-05-27 Impact factor: 5.315
Authors: Thorsten Derlin; Azien Laqmani; Simon Veldhoen; Ivayla Apostolova; Francis Ayuk; Gerhard Adam; Nicolaus Kröger; Peter Bannas Journal: Eur Radiol Date: 2014-11-23 Impact factor: 5.315